This is a snippet of the transcript, sign up to read more.
To give you a sense of the numbers, in 2019 and 2020, about 50% of the complaints were about premium increases. Around 35% to 40% were related to claim denials, pre-existing conditions, waiting periods, and the like. The remaining 10% were various issues such as perceived miscalculations of deductibles or customer service-related issues.
This is a snippet of the transcript, sign up to read more.
Most of our complaints, about 50%, come from California, which is our largest state, followed by New York and New Jersey. The majority of the complaints from California in the past have been about premium increases, which we can't control because the rates are approved by the state. If customers want to complain about the rates, they should direct their complaints to the California Department of Insurance, which approves the rates.
This is a snippet of the transcript, sign up to read more.
The Maine regulations, including the removal of the waiting period and the impact of regulations on insurance, came into effect on January 1, 2023. This affected many people because waiting periods were no longer allowed. They were only removed for accidents that are considered acute. Previously, acute related accidents or illnesses were preexisting, but now they must be covered. For example, when you sign a contract, say on January 31, you couldn't submit a claim for 15 days, no matter what happened. Even if there was an accident, you couldn't submit a claim due to the waiting period. However, the new law states that there can't be a waiting period for any acute accident-related injuries or illnesses. If you buy the policy now, on July 31, and your dog gets hit by a car tomorrow, it must be covered.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research